Tamilnad Mercantile Bank lists at ₹510, lower than grey market estimates

• Shares of Tamilnad Mercantile Bank listed at ₹510 while the shares were allotted at ₹500 per share.
• The IPO was subscribed 2.86 times amidst volatile market conditions.
• The market capitalisation of the company stood at ₹8,075 crore.

Thoothukudi-based Tamilnad Mercantile Bank listed at ₹510 on the bourses today, higher than its IPO price of ₹500. The ₹10 listing premium is less than what the grey market had predicted.

The IPO’s grey market premium has been falling since it opened. As of yesterday, it stood at ₹15. It was pegged at ₹35 when the IPO opened.

The market capitalisation of the company stands at ₹8,075 crore, according to BSE data.

Analysts had predicted a tepid listing for the company’s shares.

“We expect a flat or a negative listing based on the current GMP or ₹12 i.e. 2.5% over its issue price and less than stellar subscription numbers. We had assigned avoid rating because of the precarious legal challenges and the lack of complete clarity on the management’s long-term performance despite the improvement in fundamentals in the last three years,” Aayush Agrawal, senior research analyst at Swastika Investmart.

The IPO was subscribed 2.86 times amidst volatile market conditions. The retail portion of the IPO saw a subscription of 6.48 times the offer.

The proceeds from the IPO will be used to augment tier-I capital base to meet future capital requirements.

As of March 31, 2022, the lender has 509 branches, of which 106 branches are in rural, 247 in semi-urban, 80 in urban and 76 in metropolitan centres. Its advances portfolio primarily consists of retail customers, agricultural customers and MSMEs.

The bank has built a strong network of customers in the state of Tamil Nadu. As of March 31, 2022 Tamil Nadu contributed to 75% of its deposits and advances.

Adding to it, the bank’s profitability nearly doubled in the last three financial years.


SEE ALSO: The bill for India's renewable energy goals by 2030 – $560 billion
Medicines and Biryani from the sky: Made-In-India drones witness growth post import ban